Yat Sun Or

2019

In 2019, Yat Sun Or earned a total compensation of $1.6M as Senior Vice President, Research & Development and Chief Scientific Officer at Enanta Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$162,969
Option Awards$890,470
Salary$453,900
Stock Awards$104,324
Other$19,151
Total$1,630,814

Or received $890.5K in option awards, accounting for 55% of the total pay in 2019.

Or also received $163K in non-equity incentive plan, $453.9K in salary, $104.3K in stock awards and $19.2K in other compensation.

Rankings

In 2019, Yat Sun Or's compensation ranked 6,905th out of 13,971 executives tracked by ExecPay. In other words, Or earned more than 50.6% of executives.

ClassificationRankingPercentile
All
6,905
out of 13,971
51st
Division
Manufacturing
2,637
out of 5,692
54th
Major group
Chemicals And Allied Products
958
out of 2,189
56th
Industry group
Drugs
809
out of 1,875
57th
Industry
Pharmaceutical Preparations
593
out of 1,387
57th

Pay ratio

Yat Sun Or's Pay$1,630,814
Median Employee's Pay$260,099
Pay Ratio

6

to 1

In 2019, the annual total compensation of Yat Sun Or was $1,630,814.

The annual total compensation of the median employee at Enanta Pharmaceuticals was $260,099.

The ratio of Yat Sun Or's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on January 17, 2020.

Or's colleagues

We found four more compensation records of executives who worked with Yat Sun Or at Enanta Pharmaceuticals in 2019.

2019

Jay Luly

Enanta Pharmaceuticals

Chief Executive Officer

2019

Nathalie Adda

Enanta Pharmaceuticals

Chief Medical Officer

2019

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

2019

Nathaniel Gardiner

Enanta Pharmaceuticals

General Counsel

News

In-depth

You may also like